Literature DB >> 6681319

Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease.

J I Gallin, E S Buescher.   

Abstract

A common characteristic of the response to infection seen in patients with chronic granulomatous disease (CGD) is an exaggerated and prolonged inflammatory response with frequent development of draining lymph nodes and granuloma formation. Recent reports of several CGD patients with minor but significant in vitro abnormalities of cellular and humoral components of neutrophil chemotactic responses would predict lessened responses to inflammatory stimuli. The following studies were, therefore, performed to assess in vivo inflammatory responses in patients with CGD. Twenty-four-hour Rebuck skin-window procedures were performed on eight patients (five male and three female) with CGD and on ten volunteers. The windows were changed 1, 3, 5, 8, 12, and 24 h after the abrasion. Quantitation of the skin windows was performed with the assistance of a microscope-image analyzer computer facility. Neutrophil accumulation into skin windows was normal in CGD patients throughout the first 5 h. However, during the 8- to 24-h period, when neutrophils characteristically disappear from normal inflammatory responses and are replaced by monocytes, there was abnormal persistence of PMN at the inflammatory foci in male but not in female CGD patients (P less than 0.05 for the comparison of the rates of decline of PMN, from hour 8 to hour 24, in five male CGDs and in 10 normals). Monocyte recruitment was normal. In one CGD male, the abnormal skin-window response was normalized while he was receiving white cell transfusions. The data indicate that there is an abnormal "turn off" of the acute inflammatory response in male CGD patients and support a modulatory role for products of oxidative metabolism on the inflammatory response.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1983        PMID: 6681319     DOI: 10.1007/bf00917259

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  19 in total

1.  A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products.

Authors:  D G Wright; J I Gallin
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

2.  Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.

Authors:  P Venge; I Olsson
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

Review 3.  Chronic granulomatous disease.

Authors:  R B Johnston; S L Newman
Journal:  Pediatr Clin North Am       Date:  1977-05       Impact factor: 3.278

4.  A variant of chronic granulomatous disease: deficient oxidative metabolism due to a low-affinity NADPH oxidase.

Authors:  P D Lew; F S Southwick; T P Stossel; J C Whitin; E Simons; H J Cohen
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

5.  Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine.

Authors:  R A Clark; S Szot; K Venkatasubramanian; E Schiffmann
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Correlation between membrane potential changes and superoxide production in human granulocytes stimulated by phorbol myristate acetate. Evidence for defective activation in chronic granulomatous disease.

Authors:  J C Whitin; C E Chapman; E R Simons; M E Chovaniec; H J Cohen
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

7.  Chronic granulomatous disease: studies of a family with impaired neutrophil chemotactic, metabolic and bactericidal function.

Authors:  F A Clark; S J Klebanoff
Journal:  Am J Med       Date:  1978-12       Impact factor: 4.965

8.  Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.

Authors:  R A Clark; S J Klebanoff
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

Review 9.  Congenital disorders of the function of polymorphonuclear neutrophils.

Authors:  E L Mills; P G Quie
Journal:  Rev Infect Dis       Date:  1980 May-Jun

10.  Phagocytosing human neutrophils inactivate their own granular enzymes.

Authors:  A A Voetman; R S Weening; M N Hamers; L J Meerhof; A A Bot; D Roos
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  22 in total

Review 1.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Neutrophils regulate tissue Neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine.

Authors:  S Courtney Frasch; Ruby F Fernandez-Boyanapalli; Karin A Zemski Berry; Robert C Murphy; Christina C Leslie; Jerry A Nick; Peter M Henson; Donna L Bratton
Journal:  J Biol Chem       Date:  2013-01-05       Impact factor: 5.157

3.  The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs.

Authors:  B H Segal; T M Doherty; T A Wynn; A W Cheever; A Sher; S M Holland
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Enhancement of normal neutrophil chemiluminescence by chronic granulomatous disease neutrophils.

Authors:  R L Roberts; B J Ank; E R Stiehm
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

5.  Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils.

Authors:  G J Peppin; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Kathleen McPhillips; R William Vandivier; Brian L Harry; David W H Riches; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  NADPH oxidase limits innate immune responses in the lungs in mice.

Authors:  Brahm H Segal; Wei Han; Jennifer J Bushey; Myungsoo Joo; Zahida Bhatti; Joy Feminella; Carly G Dennis; R Robert Vethanayagam; Fiona E Yull; Maegan Capitano; Paul K Wallace; Hans Minderman; John W Christman; Michael B Sporn; Jefferson Chan; Donald C Vinh; Steven M Holland; Luigina R Romani; Sarah L Gaffen; Michael L Freeman; Timothy S Blackwell
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

8.  Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model.

Authors:  Maren von Köckritz-Blickwede; Manfred Rohde; Sonja Oehmcke; Lloyd S Miller; Ambrose L Cheung; Heiko Herwald; Simon Foster; Eva Medina
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

9.  Modified skin window technique for the extended characterisation of acute inflammation in humans.

Authors:  D J B Marks; M Radulovic; S McCartney; S Bloom; A W Segal
Journal:  Inflamm Res       Date:  2007-04       Impact factor: 4.575

Review 10.  Regulation of innate immunity by NADPH oxidase.

Authors:  Brahm H Segal; Melissa J Grimm; A Nazmul H Khan; Wei Han; Timothy S Blackwell
Journal:  Free Radic Biol Med       Date:  2012-05-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.